- FDA approves Upsher-Smith's Qudexy XR extended-release capsules
- 21 health industry groups address FDA on proposed changes to generic drug label rules
- Mylan launches generic drug for kidney transplant patients
- USPLabs agrees to recall and destroy dietary supplement following FDA actions
- Senate passes Drug Quality and Security Act
PITTSBURGH — The Food and Drug Administration has approved a generic drug for epilepsy made by Mylan.
Mylan said Monday that the FDA had approved its divalproex sodium capsules in the 125-mg strength. The drug is a generic version of Abbott’s Depakote Sprinkle capsules and is used to treat certain types of epileptic seizures.
Divalproex sodium capsules had sales of about $89 million during the 12-month period ended in March, according to IMS Health.